Bill's Page Views

This Week: 7   All-Time: 169

H.R.5629

0 Comments

My Vote  All Votes
AyeAyes:0
NayNays:0

Pathway for Biosimilars Act

To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes.

Other Bill Titles (2 more)

3/13/2008--Introduced.
Pathway for Biosimilars Act - Amends the Public Health Service Act to allow a person to submit an application for licensure of a biological product based on its similarity to a licensed biological product (the reference product).
Requires the Secretary of Hea... moreSee Full Bill Text

Amendments

This bill has no amendments.



Bill Status

Make a Bill Status Widget Question
IntroducedresultVoted on by HouseresultVoted on by SenateresultConsidered By PresidentresultBill Becomes Law
March 13, 2008
Show All Actions (6 actions)


In the News feed

March 26, 2008 New US biosimilars bill a disappointing distraction, says GPhA

HR 5629, the bipartisan Pathway for Biosimilars Act introduced in the House by Representatives Anna Eshoo (Democrat, California) and Representative Joe ...

Was this article useful? Yes or No

Source: In-PharmaTechnologist.com, UK


March 18, 2008 California Healthcare Institute Supports Introduction of ...

... March 14, to Congresswoman Anna Eshoo (D-Menlo Park) commending her for the introduction of HR 5629, the “Pathway for Biosimilars Act,” legislation that ...

Was this article useful? Yes or No

Source: Earthtimes, UK


See most useful news articles

Blog Coverage feed

June 26, 2008 Biogenerics Would Save How Much?

The bills, by the way, are S. 1695, the Biologics Price Competition and Innovation Act of 2007; HR 1956, the Patient Protection and Innovative Biologic Medicines Act of 2007; and HR 5629, the Pathway for Biosimilars Act. If you go to ...

Was this article useful? Yes or No

Source: Pharmalot


June 15, 2008 [IHRO] Ariyan Invasion; The Indus Valley Decipherment Hoax ...

1 ((sup)*(/sup), HR 5629, ASI 63.10.371, HU 441; photographed by Erja Lahdenper. Courtesy ASI, Government of India. H-103a, Vol. 1 (*), 2789, ASI 63.11.116, HU 601; photographed by Erja Lahdenper. Courtesy ASI, Government of India. ...

Was this article useful? Yes or No

Source: Human Rights Movements


June 11, 2008 Letter: Data Exclusivity a Necessity for Creation of New Biologics

Anna G. Eshoo, D-Calif., and Joe L. Barton, R-Texas, in support of the lawmakers’ legislation that would create an approval pathway for follow-on biologics (HR 5629). The letter highlights the bill’s proposed data exclusivity period as ...

Was this article useful? Yes or No

Source: CQ healthbeat News


9 more posts...
See most useful blog posts

Information made available by:

Technorati

For more info about the campaign contributions behind this bill, visit its page on Maplight.org

OpenCongress is a joint project of the Participatory Politics Foundation and the Sunlight Foundation. Questions? Comments? Contact Us

Data made available by:

Govtrack.US

Help Open Up Congress:

The OpenHouse Project